Explore the groundbreaking concept of immunogenic cell death (ICD) in the context of high-grade gliomas. This episode highlights how ICD can turn dying tumor cells into activators of the immune response, opening new doors in glioma therapy. Discover its implications for treatment resistance, immune system modulation, and prognostic strategies in aggressive brain tumors.